Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 1846 AL 1860

Recent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson's disease models

Ganesan P, Ko HM, Kim IS, Choi DK.

Int J Nanomedicine. 2015 Oct 29;10:6757-72. doi: 10.2147/IJN.S93918. eCollection 2015.

Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases

Pedersen BK, Saltin B.

Scand J Med Sci Sports. 2015 Dec;25 Suppl 3:1-72. doi: 10.1111/sms.12581.

DADS neuropathy associated with anti-TNF-α therapy

McGinty RN, McNamara B, Moore H.

BMJ Case Rep. 2015 Nov 25;2015:bcr2015211781. doi: 10.1136/bcr-2015-211781.

High Frequency Deep Brain Stimulation and Neural Rhythms in Parkinson's Disease

Blumenfeld Z, Brontë-Stewart H.

Neuropsychol Rev. 2015 Dec;25(4):384-97. doi: 10.1007/s11065-015-9308-7. Epub 2015 Nov 25.

Cognitive impairment in Parkinson's disease

Ransmayr G.

Psychiatr Danub. 2015 Dec;27(4):458-61.

Supine sleep and obstructive sleep apnea syndrome in Parkinson's disease

Cochen De Cock V, Benard-Serre N, Driss V, Granier M, Charif M, Carlander B, Desplan M, Croisier Langenier M, Cugy D, Bayard S.

Sleep Med. 2015 Dec;16(12):1497-501. doi: 10.1016/j.sleep.2014.09.014. Epub 2015 Apr 14.

Parkinson's Disease in the Gulf Countries: An Updated Review

Alamri Y, MacAskill M, Anderson T, Benamer H.

Eur Neurol. 2015;74(3-4):222-5. doi: 10.1159/000442283. Epub 2015 Nov 28.

Intracellular Dynamics of Synucleins: "Here, There and Everywhere"

Surguchov A.

Int Rev Cell Mol Biol. 2015;320:103-69. doi: 10.1016/bs.ircmb.2015.07.007. Epub 2015 Aug 17.

Alpha-synuclein Toxicity in the Early Secretory Pathway: How It Drives Neurodegeneration in Parkinsons Disease

Wang T, Hay JC.

Front Neurosci. 2015 Nov 12;9:433. doi: 10.3389/fnins.2015.00433. eCollection 2015.

Effects of Auditory Rhythm and Music on Gait Disturbances in Parkinson's Disease

Ashoori A, Eagleman DM, Jankovic J.

Front Neurol. 2015 Nov 11;6:234. doi: 10.3389/fneur.2015.00234. eCollection 2015.

Cell Therapy for Parkinson's Disease: New Hope from Reprogramming Technologies

Chen Z.

Aging Dis. 2015 Nov 17;6(6):499-503. doi: 10.14336/AD.2014.1201. eCollection 2015 Nov.

Levodopa-Carbidopa Intestinal Gel Infusion Therapy in Advanced Parkinson's Disease: Single Middle Eastern Center Experience

Bohlega S, Abou Al-Shaar H, Alkhairallah T, Al-Ajlan F, Hasan N, Alkahtani K.

Eur Neurol. 2015;74(5-6):227-36. doi: 10.1159/000442151. Epub 2015 Dec 1.

Skin biomarkers for neurodegenerative disease: a future perspective

Castanedo-Cazares JP, Rodriguez-Leyva I.

Neurodegener Dis Manag. 2015 Dec;5(6):465-7. doi: 10.2217/nmt.15.51. Epub 2015 Nov 30.

Elderly patients' participation in clinical trials

Shenoy P, Harugeri A.

Perspect Clin Res. 2015 Oct-Dec;6(4):184-9. doi: 10.4103/2229-3485.167099.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias